These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3560860)

  • 21. 16S rRNA gene sequence-based analysis of clostridia related to conversion of germfree mice to the normal state.
    Momose Y; Maruyama A; Iwasaki T; Miyamoto Y; Itoh K
    J Appl Microbiol; 2009 Dec; 107(6):2088-97. PubMed ID: 19614852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate postnatal inoculation of a microbial barrier to prevent neonatal diarrhea induced by Clostridium difficile in young conventional and gnotobiotic hares.
    Dubos F; Martinet L; Dabard J; Ducluzeau R
    Am J Vet Res; 1984 Jun; 45(6):1242-4. PubMed ID: 6742589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth inhibition of Clostridium difficile by intestinal flora of infant faeces in continuous flow culture.
    Yamamoto-Osaki T; Kamiya S; Sawamura S; Kai M; Ozawa A
    J Med Microbiol; 1994 Mar; 40(3):179-87. PubMed ID: 8114067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transfer of the cecal flora of the hamster to the germfree C3H mouse: use of this model to study the flora of the anti-Clostridium difficile barrier].
    Su WJ; Bourlioux P; Bournaud M; Besnier MO; Fourniat J
    Can J Microbiol; 1986 Feb; 32(2):132-6. PubMed ID: 3516351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antagonistic effect against "Clostridium perfringens" exerted in the digestive tract of gnotobiotic mice by "Clostridium" strains isolated from the microflora of conventional mice (author's transl)].
    Hudault S; Raibaud P; Ducluzeau R; Bridonneau C
    Ann Microbiol (Paris); 1982; 133(3):443-59. PubMed ID: 6285793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dalbavancin on the normal intestinal microflora.
    Nord CE; Rasmanis G; Wahlund E
    J Antimicrob Chemother; 2006 Sep; 58(3):627-31. PubMed ID: 16840427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic residues and drug resistance in human intestinal flora.
    Corpet DE
    Antimicrob Agents Chemother; 1987 Apr; 31(4):587-93. PubMed ID: 3300533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of roxithromycin on fecal bacteria in human volunteers and resistance to colonization in gnotobiotic mice.
    Pecquet S; Chachaty E; Tancrède C; Andremont A
    Antimicrob Agents Chemother; 1991 Mar; 35(3):548-52. PubMed ID: 2039207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaerobic infections and Clostridium difficile colitis emerging during antibacterial therapy.
    Finegold SM
    Scand J Infect Dis Suppl; 1986; 49():160-4. PubMed ID: 3547621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal colonization with Clostridium difficile in infants up to 18 months of age.
    Tullus K; Aronsson B; Marcus S; Möllby R
    Eur J Clin Microbiol Infect Dis; 1989 May; 8(5):390-3. PubMed ID: 2502403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orally administered beta-lactamase enzymes represent a novel strategy to prevent colonization by Clostridium difficile.
    Stiefel U; Nerandzic MM; Koski P; Donskey CJ
    J Antimicrob Chemother; 2008 Nov; 62(5):1105-8. PubMed ID: 18693236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental models of Clostridium difficile enterocolitis in gnotobiotic mice.
    Sugiyama T; Mukai M; Yamashita R; Sunakawa K
    Prog Clin Biol Res; 1985; 181():203-6. PubMed ID: 4022975
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii.
    Corthier G; Dubos F; Ducluzeau R
    Can J Microbiol; 1986 Nov; 32(11):894-6. PubMed ID: 3815159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial interference between Clostridium difficile and normal fecal flora.
    Rolfe RD; Helebian S; Finegold SM
    J Infect Dis; 1981 Mar; 143(3):470-5. PubMed ID: 6785366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal beta-lactamase activity in ampicillin-induced, Clostridium difficile-associated ileocecitis.
    Rolfe RD; Finegold SM
    J Infect Dis; 1983 Feb; 147(2):227-35. PubMed ID: 6600772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection.
    Naaber P; Mikelsaar RH; Salminen S; Mikelsaar M
    J Med Microbiol; 1998 Jul; 47(7):591-8. PubMed ID: 9839563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of ampicillin and pivampicillin on the intestinal flora of man].
    Knothe H; Lembke U
    Zentralbl Bakteriol Orig A; 1973 Mar; 223(2):324-32. PubMed ID: 4145839
    [No Abstract]   [Full Text] [Related]  

  • 38. [The influence of cefpirome on intestinal bacterial flora].
    Iwata S; Ikeda M; Isohata E; Kin Y; Yokota T; Kusumoto Y; Sato Y; Akita H; Oikawa T; Sunakawa K
    Jpn J Antibiot; 1991 Jan; 44(1):62-83. PubMed ID: 2041149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua.
    Cáceres M; Carera E; Palmgren AC; Nord CE
    Rev Esp Quimioter; 1998 Sep; 11(3):221-8. PubMed ID: 9795308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on Clostridium difficile and antimicrobial associated diarrhea or colitis].
    Kobayashi T
    Jpn J Antibiot; 1983 Feb; 36(2):464-76. PubMed ID: 6854944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.